These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12016292)

  • 1. Corporate research. Japan's drugmakers need a boost to compete.
    Normile D
    Science; 2002 May; 296(5571):1231. PubMed ID: 12016292
    [No Abstract]   [Full Text] [Related]  

  • 2. More focus urged for Japan's drug research.
    Nature; 1995 Feb; 373(6516):649. PubMed ID: 7854428
    [No Abstract]   [Full Text] [Related]  

  • 3. Japan's foundations still building.
    Swinbanks D
    Nature; 1993 Feb; 361(6414):761-4. PubMed ID: 8441475
    [No Abstract]   [Full Text] [Related]  

  • 4. Stepping up to the plate.
    Nat Immunol; 2008 Jan; 9(1):1. PubMed ID: 18087245
    [No Abstract]   [Full Text] [Related]  

  • 5. Antarctic research frozen out of Japan's budget plans.
    Kandachi K
    Nature; 2003 Nov; 426(6963):108. PubMed ID: 14614464
    [No Abstract]   [Full Text] [Related]  

  • 6. Newsmaker interview. Tonegawa rethinks Japan's premier brain research center. Interview by Dennis Normile.
    Tonegawa S
    Science; 2009 Oct; 326(5951):352. PubMed ID: 19833932
    [No Abstract]   [Full Text] [Related]  

  • 7. Money woes fail to weaken Japan's support for science.
    Swinbanks D
    Nature; 1996 Jan; 379(6561):105. PubMed ID: 8538753
    [No Abstract]   [Full Text] [Related]  

  • 8. Japan's boom economy invests in science.
    Swinbanks D
    Nature; 1990 Jan; 343(6255):195. PubMed ID: 2300153
    [No Abstract]   [Full Text] [Related]  

  • 9. The European pharmaceutical outlook.
    Nature; 1993 Feb; 361(6414):765-8. PubMed ID: 8441477
    [No Abstract]   [Full Text] [Related]  

  • 10. Japan's science budget expands.
    Anderson A
    Nature; 1989 Feb; 337(6206):394. PubMed ID: 2915679
    [No Abstract]   [Full Text] [Related]  

  • 11. University-industry collaboration. Last of the big-time spenders?
    Lawler A
    Science; 2003 Jan; 299(5605):330-3. PubMed ID: 12531991
    [No Abstract]   [Full Text] [Related]  

  • 12. Japan's desire to lead in IT fuels latest budget requests.
    Cyranoski D
    Nature; 2000 Sep; 407(6800):4. PubMed ID: 10993040
    [No Abstract]   [Full Text] [Related]  

  • 13. Nuclear safety and biotech boosted in Japan's budget.
    Saegusa A
    Nature; 1999 Dec; 402(6761):451. PubMed ID: 10591194
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug research. Novartis sows its future in U.S. soil.
    Lawler A
    Science; 2002 May; 296(5571):1216-7. PubMed ID: 12016279
    [No Abstract]   [Full Text] [Related]  

  • 15. A fond farewell.
    Nat Immunol; 2000 Aug; 1(2):89. PubMed ID: 11248792
    [No Abstract]   [Full Text] [Related]  

  • 16. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
    Dorfman HL; Reig LP
    Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
    [No Abstract]   [Full Text] [Related]  

  • 17. Dundee: discovering life sciences.
    Tasker H
    Drug Discov Today; 2006 May; 11(9-10):379-82. PubMed ID: 16635798
    [No Abstract]   [Full Text] [Related]  

  • 18. Spanish biomedical centres face funding uncertainty.
    Bosch X
    Nature; 2000 Aug; 406(6796):550. PubMed ID: 10949265
    [No Abstract]   [Full Text] [Related]  

  • 19. Japan creeps toward proteomics.
    Saegusa A
    Nat Biotechnol; 2000 Jan; 18(1):16-7. PubMed ID: 10625377
    [No Abstract]   [Full Text] [Related]  

  • 20. Fidia and neuroscience.
    Bernardi G; Biggio G; Erspamer V; Fratta W; Gessa GL; Mantegazza P; Moroni F; Pepeu G
    Nature; 1993 Dec; 366(6454):399. PubMed ID: 8247140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.